spacer
home > ebr > summer 2004 > driving productivity through strategic partnering
PUBLICATIONS
European Biopharmaceutical Review

Driving Productivity through Strategic Partnering

It has been said: "research takes money and generates ideas, innovation takes ideas and generates money". In reality, a pharmaceutical company must be successful at both if it is to continue to create exciting new medicines offering significant improvements to patients' lives. No single company has a monopoly on innovation, so pharmaceutical manufacturers need to continually find ways to complement their strong internal research with creative external alliances. Analysts expect that more than 50 per cent of new drug approvals in 2004 will originate from the biotech sector, highlighting the importance of accessing this source of innovation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Nigel Sheail, Global Head, Strategic Alliances & Acquisitions at Roche Pharma Partnering

Nigel Sheail is Global Head of Strategic Alliances & Acquisitions at Roche Pharma Partnering. He started at Roche as a local Finance Director, setting up the company's operations in China, and later worked as the Global Controller for Research. Nigel, originally trained as a Molecular Biologist and a qualified Chartered Accountant, held several positions at GlaxoSmithKline before joining Roche more than 10 years ago. Nigel's Strategic Alliances & Acquisitions team is responsible for identifying and accessing strategic partnering opportunities. He has been responsible for a broad range of deals from research and technology collaborations through to Phase III product licensing opportunities.

spacer
Nigel Sheail
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement